Emma Ramnarine, PhD Boehringer-Ingelheim

Dr. Emma Ramnarine is an accomplished senior leader with 22+ years of global experience in the pharmaceutical, biotechnology and medical device industries in Analytical Science & Technology, Product Lifecycle Management, Outsourcing & External Collaborations, Risk Management, QC and Quality Management Systems. She was most recently Executive Director, Global Head of External Development Collaborations at Genentech/Roche, managing the external network for development, manufacturing, and clinical collaborations of Roche’s Biologics and Small Molecules development portfolio.

She is a well-recognized industry thought leader and expert on QRM and risk-based applications, providing expertise and training for regulatory authorities and the industry. She is currently Co-lead for the Industry One-Voice-of-Quality (1VQ) Initiative on Post Approval Changes, an initiative sponsored by Chief Quality Officers of more than 25 global pharma companies.

Emma is currently Secretary of the PDA Board and is in the Board since 8 y. She was also on RAQAB, and has led several PDA Task Forces, Interest Group and Technical Reports (TR).

Emma holds a PhD in Pharmaceutical Sciences from TU Dublin, Ireland, an MS in Pharmaceutical Sciences from the University of Connecticut, an M Pharm and a B Pharm, both from the School of Pharmacy, SGSITS, Indore, India.